| Application no. and date | 11838863.6 (espacenet) (Federated) (European Patent Register), 20111104 | | Patent/reg. no. and date | DK/EP 2635297, 20190227 | | Publication date | 20130911 | | Priority no. and date | US 410437 P, 20101105 | | EP pub. no. and date |
EP 2635297 20130911 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku
Osaka-Shi, Osaka, JP | | Applicant ref. no. | P67833DK01 | | Inventor | LAI, Chee Kong, 1 Silver Birch Lane
Littleton
MA 01460, US,
STAFFORD, Roddy, Kevin, 234 Spring Street
Shrewsbury
MA 01545, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 35/14 (2015.01) , A61K 38/37 (2006.01) | | Title | EN NY VARIANT AF ANTIHÆMOFIL FAKTOR VIII, DER HAR EN ØGET SPECIFIK AKTIVITET | | Int. application no. | US2011059297 | | Int. publication no. | WO2012061689 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
